Thyroid Gland Disorder Market

Thyroid Gland Disorders Treatment Market (Disorders - Hypothyroidism (Levothyroxine and Liothyronine) and Hyperthyroidism (Imidazole and Propacil)) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2017 - 2025

  • Rep Id : TMRGL3113
  • Published On : Feb 2018
  • No. of Pages : 173
  • Category : Pharmaceutical

1. Preface 
     1.1. Report Scope and Market Segmentation 
     1.2. Research Highlights

2. Assumptions and Research Methodology 
     2.1. Assumptions and Acronyms Used
     2.2. Research Methodology

3. Executive Summary
     3.1. Global Thyroid Gland Disorders Treatment Market Size (US$ Mn) and Distribution, by Region, 2017 and 2025 
     3.2. Global Thyroid Gland Disorders Treatment Market: Market Snapshot

4. Market Overview
     4.1. Global Thyroid Gland Disorders Treatment Market: Product Overview 
     4.2. Global Thyroid Gland Disorders Treatment Market: Key Industry Developments

5. Market Dynamics
     5.1. Drivers and Restraints Snapshot Analysis
     5.2. Drivers
            5.2.1. Increasing incidence of thyroid gland disorders
            5.2.2. Rise in the number of obese, diabetic, and cardiovascular patients, leading to increased risk of thyroid disorders
            5.2.3. Growing number of disease awareness programs in developing regions 
            5.2.4. Focus on spreading awareness about disorders as well as promotional campaigns
            5.2.5. Development of effective combination thyroid disorders drug therapies
     5.3. Restraints
            5.3.1. Rising customer preference for alternative treatments 
            5.3.2. Asymptomatic nature of thyroid disorders leading to large pool of undiagnosed patients
     5.4.  Opportunities
            5.4.1. Asymptomatic nature of thyroid disorders leading to large pool of undiagnosed patients
            5.4.2. Increase in research and development activities
     5.5. Global Thyroid Gland Disorders (Hypothyroidism and Hyperthyroidism) Epidemiology
     5.6. Global Thyroid Gland Disorders Treatment Market Revenue Forecast
     5.7. Global Thyroid Gland Disorders Treatment Market Outlook

6. Global Thyroid Gland Disorders Treatment Market Analysis, by Disorders
     6.1. Introduction
     6.2. Key Insights
     6.3. Global Thyroid Gland Disorders Treatment Market Analysis, by Disorders
            6.3.1. Hypothyroidism
                     6.3.1.1. Levothyroxine
                     6.3.1.2. Liothyronine
            6.3.2. Hyperthyroidism
                     6.3.2.1. Imidazole
                     6.3.2.2. Propacil
     6.4. Global Thyroid Gland Disorders Treatment Market Forecast, by Disorders
            6.4.1. Hypothyroidism
                     6.4.1.1. Levothyroxine
                     6.4.1.2. Liothyronine
            6.4.2. Hyperthyroidism
                     6.4.2.1. Imidazole
                     6.4.2.2. Propacil
     6.5. Global Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorders
            6.5.1. Hypothyroidism
            6.5.2. Hyperthyroidism

7. Global Thyroid Gland Disorders Treatment Market Analysis, by Region
     7.1. Global Thyroid Gland Disorders Treatment Market Forecast, by Region, 2015–2025 
            7.1.1. North America
            7.1.2. Europe
            7.1.3. Asia Pacific
            7.1.4. Latin America
            7.1.5. Middle East & Africa
     7.2. Global Thyroid Gland Disorders Treatment Market Value Share Analysis, by Region
     7.3. Global Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Region

8. North America Thyroid Gland Disorders Treatment Market Analysis
     8.1. North America Thyroid Gland Disorders Treatment Market Key Findings
     8.2. North America Thyroid Gland Disorders Treatment Market Overview
     8.3. North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders
            8.3.1. Hypothyroidism
                     8.3.1.1. Levothyroxine
                     8.3.1.2. Liothyronine
            8.3.2. Hyperthyroidism
                     8.3.2.1. Imidazole
                     8.3.2.2. Propacil
     8.4. North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders
            8.4.1. Hypothyroidism
            8.4.2. Hyperthyroidism
     8.5. North America Thyroid Gland Disorders Treatment Market Forecast, by Country
            8.5.1. U.S.
            8.5.2. Canada
     8.6. North America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorders
            8.6.1. Hypothyroidism
            8.6.2. Hyperthyroidism

9. Europe Thyroid Gland Disorders Treatment Market Analysis
     9.1. Europe Thyroid Gland Disorders Treatment Market Key Findings
     9.2. Europe Thyroid Gland Disorders Treatment Market Overview
     9.3. Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders
            9.3.1. Hypothyroidism
                     9.3.1.1. Levothyroxine
                     9.3.1.2. Liothyronine
            9.3.2. Hyperthyroidism
                     9.3.2.1. Imidazole
                     9.3.2.2. Propacil
     9.4. Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders
            9.4.1. Hypothyroidism
            9.4.2. Hyperthyroidism
     9.5. Europe Thyroid Gland Disorders Treatment Market Forecast, by Country
            9.5.1. Germany
            9.5.2. U.K.
            9.5.3. France
            9.5.4. Italy
            9.5.5. Spain
            9.5.6. Rest of Europe
     9.6. Europe Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorders
            9.6.1. Hypothyroidism
            9.6.2. Hyperthyroidism

10. Asia Pacific Thyroid Gland Disorders Treatment Market Analysis
     10.1. Asia Pacific Thyroid Gland Disorders Treatment Market Key Findings
     10.2. Asia Pacific Thyroid Gland Disorders Treatment Market Overview
     10.3. Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders
            10.3.1. Hypothyroidism
                     10.3.1.1. Levothyroxine
                     10.3.1.2. Liothyronine
            10.3.2. Hyperthyroidism
                     10.3.2.1. Imidazole
                     10.3.2.2. Propacil
     10.4. Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders
            10.4.1. Hypothyroidism
            10.4.2. Hyperthyroidism
     10.5. Asia Pacific Thyroid Gland Disorders Treatment Market Forecast, by Country
            10.5.1. China
            10.5.2. India
            10.5.3. Japan
            10.5.4. Australia & New Zealand
            10.5.5. Rest of Asia Pacific
     10.6. Asia Pacific Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorders
            10.6.1. Hypothyroidism
            10.6.2. Hyperthyroidism

11. Latin America Thyroid Gland Disorders Treatment Market Analysis
     11.1. Latin America Thyroid Gland Disorders Treatment Market Key Findings
     11.2. Latin America Thyroid Gland Disorders Treatment Market Overview
     11.3. Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders
            11.3.1. Hypothyroidism
                     11.3.1.1. Levothyroxine
                     11.3.1.2. Liothyronine
            11.3.2. Hyperthyroidism
                     11.3.2.1. Imidazole
                     11.3.2.2. Propacil
     11.4. Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders
            11.4.1. Hypothyroidism
            11.4.2. Hyperthyroidism
     11.5. Latin America Thyroid Gland Disorders Treatment Market Forecast, by Country
            11.5.1. Brazil
            11.5.2. Mexico
            11.5.3. Rest of Latin America
     11.6. Latin America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorders
            11.6.1. Hypothyroidism
            11.6.2. Hyperthyroidism

12. Middle East & Africa Thyroid Gland Disorders Treatment Market Analysis
     12.1. Middle East & Africa Thyroid Gland Disorders Treatment Market Key Findings
     12.2. Middle East & Africa Thyroid Gland Disorders Treatment Market Overview
     12.3. Middle East & Africa Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders
            12.3.1. Hypothyroidism
                     12.3.1.1. Levothyroxine
                     12.3.1.2. Liothyronine
            12.3.2. Hyperthyroidism
                     12.3.2.1. Imidazole
                     12.3.2.2. Propacil
     12.4. Middle East & Africa Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders
            12.4.1. Hypothyroidism
            12.4.2. Hyperthyroidism
     12.5. Middle East & Africa Thyroid Gland Disorders Treatment Market Forecast, by Country
            12.5.1. GCC Countries
            12.5.2. South Africa
            12.5.3. Israel
            12.5.4. Rest of Middle East & Africa
     12.6. Middle East & Africa Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorders
            12.6.1. Hypothyroidism
            12.6.2. Hyperthyroidism

13. Competition Landscape
     13.1. Global Thyroid Gland Disorders Treatment Market Share Analysis, by Company (2016)
     13.2. Company Profiles
            13.2.1. Merck KGaA  
                     13.2.1.1. Overview (HQ, Employee Strength, Business Segments)
                     13.2.1.2. Financials
                     13.2.1.3. Recent Developments
                     13.2.1.4. Strategy
            13.2.2. Pfizer, Inc.  
                     13.2.2.1. Overview (HQ, Employee Strength, Business Segments)
                     13.2.2.2. Financials
                     13.2.2.3. Recent Developments
                     13.2.2.4. Strategy
            13.2.3. Takeda Pharmaceutical Company Limited
                     13.2.3.1. Overview (HQ, Employee Strength, Business Segments)
                     13.2.3.2. Financials
                     13.2.3.3. Recent Developments
                     13.2.3.4. Strategy
            13.2.4. ALLERGAN
                     13.2.4.1. Overview (HQ, Employee Strength, Business Segments)
                     13.2.4.2. Financials
                     13.2.4.3. Recent Developments
                     13.2.4.4. Strategy
            13.2.5. Sanofi S.A. 
                     13.2.5.1. Overview (HQ, Employee Strength, Business Segments)
                     13.2.5.2. Financials
                     13.2.5.3. Recent Developments
                     13.2.5.4. Strategy
            13.2.6. AbbVie Inc.  
                     13.2.6.1. Overview (HQ, Employee Strength, Business Segments)
                     13.2.6.2. Financials
                     13.2.6.3. Recent Developments
                     13.2.6.4. Strategy
            13.2.7. Lannett Company, Inc.
                     13.2.7.1. Overview (HQ, Employee Strength, Business Segments)
                     13.2.7.2. Financials
                     13.2.7.3. Recent Developments
                     13.2.7.4. Strategy
            13.2.8. Aspen
                     13.2.8.1. Overview (HQ, Employee Strength, Business Segments)
                     13.2.8.2. Financials
                     13.2.8.3. Recent Developments
                     13.2.8.4. Strategy
            13.2.9. Novartis AG
                     13.2.9.1. Overview (HQ, Employee Strength, Business Segments)
                     13.2.9.2. Financials
                     13.2.9.3. Recent Developments
                     13.2.9.4. Strategy
            13.2.10. Mylan N.V.
                     13.2.10.1. Overview (HQ, Employee Strength, Business Segments)
                     13.2.10.2. Financials
                     13.2.10.3. Recent Developments
                     13.2.10.4. Strategy

List of Tables

TABLE 1 Global Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2015–2025
TABLE 2 Global Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hypothyroidism Drug Class,
TABLE 3 Global Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hyperthyroidism Drug Class,
TABLE 4 Global Thyroid Gland Disorders Treatment Market Size (US$ Mn) Forecast, by Region, 2015–2025
TABLE 5 North America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorders, 2015–2025
TABLE 6 North America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hypothyroidism Drug Class, 2015–2025
TABLE 7 North America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hyperthyroidism Drug Class, 2015–2025
TABLE 8 North America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country, 2015–2025
TABLE 9 Europe Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2015–2025
TABLE 10 Europe Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hypothyroidism Drug Class, 2015–2025
TABLE 11 Europe Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hyperthyroidism Drug Class, 2015–2025
TABLE 12 Europe Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
TABLE 13 Asia Pacific Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2015–2025
TABLE 14 Asia Pacific Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hypothyroidism Drug Class, 2015–2025
TABLE 15 Asia Pacific Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hyperthyroidism Drug Class, 2015–2025
TABLE 16 Asia Pacific Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
TABLE 17 Latin America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorder, 2015–2025
TABLE 18 Latin America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hypothyroidism Drug Class, 2015–2025
TABLE 19 Latin America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hyperthyroidism Drug Class, 2015–2025
TABLE 20 Latin America Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
TABLE 21 Middle East & Africa Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Disorders, 2015–2025
TABLE 22 Middle East & Africa Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hypothyroidism Drug Class, 2015–2025
TABLE 23 Middle East & Africa Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Hyperthyroidism Drug Class, 2015–2025
TABLE 24 Middle East & Africa Thyroid Gland Disorders Treatment Market Value (US$ Mn) Forecast, by Country/Sub-region, 2015–202

List of Figures
 
FIG. 1 Global Thyroid Gland Disorders Market Revenue (US$ Mn) Forecast and Y-o-Y Growth (%), 2017–2025
FIG. 2 Global Thyroid Gland Disorders Market Value Share, by Disorders  (2016)
FIG. 3 Global Thyroid Gland Disorders Market Value Share, by Hypothyroidism Drug Class (2016)
FIG. 4 Global Thyroid Gland Disorders Market Value Share, by Region (2016)
FIG. 5 Global Thyroid Gland Disorders Market Value Share, by Hyperthyroidism Drug Class (2016)
FIG. 6 Global Thyroid Gland Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth, by Hypothyroidism, 2015–2025
FIG. 7 Global Thyroid Gland Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth, by Hyperthyroidism, 2015–2025
FIG. 8 Global Thyroid Gland Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth, by Levothyroxine, 2015–2025 
FIG. 9 Global Thyroid Gland Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth, by Liothyronine, 2015–2025
FIG. 10 Global Thyroid Gland Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth, by Imidazole, 2015–2025
FIG. 11 Global Thyroid Gland Disorders Treatment Market Revenue (US$ Mn) and Y-o-Y Growth, by Propacil, 2015–2025
FIG. 12 Global Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2016 and 2025
FIG. 13 Global Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hypothyroidism Drug Class, 2016 and 2025
FIG. 14 Global Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hyperthyroidism Drug Class, 2016 and 2025
FIG. 15 Global Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder
FIG. 16 Global Thyroid Gland Disorders Treatment Market Value Share Analysis, by Region, 2016 and 2025
FIG. 17 Global Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Region
FIG. 18 North America Thyroid Gland Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth, 2015–2025
FIG. 19 North America Market Attractiveness Analysis, by Country
FIG. 20 North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorders, 2016 and 2025
FIG. 21 North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hypothyroidism Drug Class, 2016 and 2025
FIG. 22 North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hyperthyroidism Drug Class, 2016 and 2025
FIG. 23 North America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country, 2016 and 2025
FIG. 24 North America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder
FIG. 25 Europe Thyroid Gland Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth, 2015–2025
FIG. 26 Europe Market Attractiveness Analysis, by Country
FIG. 27 Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2016 and 2025
FIG. 28 Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hypothyroidism Drug Class, 2016 and 2025
FIG. 29 Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hyperthyroidism Drug Class, 2016 and 2025
FIG. 30 Europe Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
FIG. 31 Europe Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder, 2015–2025
FIG. 32 Asia Pacific Thyroid Gland Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth, 2015–2025
FIG. 33 Asia Pacific Market Attractiveness Analysis, by Country/Sub-region
FIG. 34 Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2016 and 2025
FIG. 35 Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hypothyroidism Drug Class, 2016 and 2025
FIG. 36 Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hyperthyroidism Drug Class, 2016 and 2025
FIG. 37 Asia Pacific Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
FIG. 38 Asia Pacific Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorders
FIG. 39 Latin America Thyroid Gland Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth, 2015–2025
FIG. 40 Latin America Market Attractiveness Analysis, by Country/Sub-region
FIG. 41 Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2016 and 2025
FIG. 42 Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hypothyroidism Drug Class, 2016 and 2025
FIG. 43 Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hyperthyroidism Drug Class, 2016 and 2025
FIG. 44 Latin America Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
FIG. 45 Latin America Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder
FIG. 46 Middle East & Africa Thyroid Gland Disorders Treatment Market Size (US$ Mn) Forecast and Y-o-Y Growth, 2015–2025
FIG. 47 Middle East & Africa Market Attractiveness Analysis, by Country/Sub-region
FIG. 48 Middle East & Africa Thyroid Gland Disorders Treatment Market Value Share Analysis, by Disorder, 2016 and 2025
FIG. 49 Middle East & Africa Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hypothyroidism Drug Class, 2016 and 2025
FIG. 50 Middle East & Africa Thyroid Gland Disorders Treatment Market Value Share Analysis, by Hyperthyroidism Drug Class, 2016 and 2025
FIG. 51 Middle East & Africa Thyroid Gland Disorders Treatment Market Value Share Analysis, by Country/Sub-region, 2016 and 2025
FIG. 52 Middle East & Africa Thyroid Gland Disorders Treatment Market Attractiveness Analysis, by Disorder
FIG. 53 Global Thyroid Gland Disorders Treatment Market Company Share Analysis (2016)
FIG. 54 Merck KGaA Revenue (US$ Bn) & Y-o-Y Growth (%), 2013–2016
FIG. 55 Merck KGaA Breakdown of Net Sales, by Region, 2016
FIG. 56 Breakdown of Net Sales, by Business Segment, 2016
FIG. 57 Merck KGaA R&D Expenses (US$ Bn) & Y-o-Y Growth (%), 2014–2016
FIG. 58 Pfizer, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
FIG. 59 Pfizer, Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2013–2016
FIG. 60 Pfizer, Inc. Breakdown of Net Sales, by Region, 2016
FIG. 61 Pfizer, Inc. Sales & Marketing Expenses (US$ Mn) and Y-o-Y Growth (%), 2013–2016
FIG. 62 Takeda Pharmaceutical Company Limited Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
FIG. 63 Takeda Pharmaceutical Company Limited R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2013–2016
FIG. 64 Takeda Pharmaceutical Company Limited Breakdown of Net Sales, by Region
FIG. 65 Takeda Pharmaceutical Company Limited Sales & Marketing Expenses (US$ Mn) and Y-o-Y Growth (%), 2013–2016
FIG. 66 ALLERGAN Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
FIG. 67 ALLERGAN R&D Spending and Sales & Marketing Expenses – Company Level, 2015–2016
FIG. 68 ALLERGAN Breakdown of Net Sales, by Operating Segment, 2016
FIG. 69 Sanofi S.A. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
FIG. 70 Sanofi S.A. R&D Spending and Sales & Marketing Expenses – Company Level, 2014–2016
FIG. 71 Sanofi S.A. Breakdown of Net Sales, by Region, 2016
FIG. 72 Sanofi S.A. Breakdown of Net Sales, by Business Segment, 2016
FIG. 73 AbbVie Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
FIG. 74 AbbVie Inc. R&D Expenses and Sales & Marketing Expenses– Company Level, 2015–2016
FIG. 75 AbbVie Inc. Breakdown of Net Sales, by Region, 2016
FIG. 76 AbbVie Inc. Breakdown of Net Sales, by Major Brands, 2016
FIG. 77 Lannett Company, Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2013–2016
FIG. 78 Lannett Company, Inc. Breakdown of Net Sales, by Business Segments, 2016
FIG. 79 Lannett Company, Inc. Breakdown of Net Sales, by Customer Distribution Channel, 2016
FIG. 80 Aspen Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
FIG. 81 Aspen R&D Expenses and Sales & Marketing Expenses(%) – Company Level, 2015–2016
FIG. 82 Aspen Breakdown of Net Sales, By Region 2016
FIG. 83 Aspen Breakdown of Net Sales, (Overall Company Level), 2016
FIG. 84 Novartis AG Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
FIG. 85 Novartis AG R&D Expenses and Sales & Marketing Expenses(%) – Company Level, 2015–2016
FIG. 86 Novartis AG Breakdown of Net Sales, By Region 2016
FIG. 87 Novartis AG Breakdown of Net Sales, Business Segments, 2016
FIG. 88 Mylan N.V. Revenue (US$ Mn) & Y-o-Y Growth (%), 2013–2016
FIG. 89 Mylan N.V. R&D Expenses and Sales & Marketing Expenses(%) – Company Level, 2015–2016
FIG. 90 Mylan N.V. Breakdown of Net Sales, By Region 2016
FIG. 91 Mylan N.V. Breakdown of Net Sales, Business Segments, 2016

.